FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3086708017> ?p ?o ?g. }

• W3086708017 endingPage "6721" @default.
• W3086708017 startingPage "6721" @default.
• W3086708017 abstract "Background: The limitations of conventional treatment modalities in cancer, especially in breast cancer, facilitated the necessity for developing a safer drug delivery system (DDS). Inorganic nano-carriers based on calcium phosphates such as hydroxyapatite (HA) and carbonate apatite (CA) have gained attention due to their biocompatibility, reduced toxicity, and improved therapeutic efficacy. Methods: In this study, the potential of goose bone ash (GBA), a natural derivative of HA or CA, was exploited as a pH-responsive carrier to successfully deliver doxorubicin (DOX), an anthracycline drug into breast cancer cells (e.g., MCF-7 and MDA-MB-231 cells). GBA in either pristine form or in suspension was characterized in terms of size, morphology, functional groups, cellular internalization, cytotoxicity, pH-responsive drug (DOX) release, and protein corona analysis. Results: The pH-responsive drug release study demonstrated the prompt release of DOX from GBA through its disintegration in acidic pH (5.5–6.5), which mimics the pH of the endosomal and lysosomal compartments as well as the stability of GBA in physiological pH (pH 7.5). The result of DOX binding with GBA indicated an increment in binding affinity with increasing concentrations of DOX. Cell viability and cytotoxicity analysis showed no innate toxicity of GBA particles. Both qualitative and quantitative cellular uptake analysis in both cell lines displayed an enhanced cellular internalization of DOX-loaded GBA compared to free DOX molecules. The protein corona spontaneously formed on the surface of GBA particles exhibited its affinity toward transport proteins, structural proteins, and a few other selective proteins. The adsorption of transport proteins could extend the circulation half-life in biological environment and increase the accumulation of the drug-loaded NPs through the enhanced permeability and retention (EPR) effect at the tumor site. Conclusion: These findings highlight the potential of GBA as a DDS to successfully deliver therapeutics into breast cancer cells." @default.
• W3086708017 created "2020-09-21" @default.
• W3086708017 creator A5045095239 @default.
• W3086708017 creator A5069198969 @default.
• W3086708017 creator A5088377898 @default.
• W3086708017 creator A5090107841 @default.
• W3086708017 date "2020-09-14" @default.
• W3086708017 modified "2023-09-26" @default.
• W3086708017 title "Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells" @default.
• W3086708017 cites W1601940465 @default.
• W3086708017 cites W1963565300 @default.
• W3086708017 cites W1964603081 @default.
• W3086708017 cites W1975088956 @default.
• W3086708017 cites W1979335059 @default.
• W3086708017 cites W1992865052 @default.
• W3086708017 cites W1996166343 @default.
• W3086708017 cites W1996697333 @default.
• W3086708017 cites W2000935840 @default.
• W3086708017 cites W2001349369 @default.
• W3086708017 cites W2002516695 @default.
• W3086708017 cites W2004827689 @default.
• W3086708017 cites W2005771030 @default.
• W3086708017 cites W2008269449 @default.
• W3086708017 cites W2008637102 @default.
• W3086708017 cites W2011269058 @default.
• W3086708017 cites W2011934424 @default.
• W3086708017 cites W2013470095 @default.
• W3086708017 cites W2014525894 @default.
• W3086708017 cites W2017791788 @default.
• W3086708017 cites W2019670596 @default.
• W3086708017 cites W2024535867 @default.
• W3086708017 cites W2041998484 @default.
• W3086708017 cites W2047302166 @default.
• W3086708017 cites W2057022635 @default.
• W3086708017 cites W2061510929 @default.
• W3086708017 cites W2067673216 @default.
• W3086708017 cites W2092647316 @default.
• W3086708017 cites W2101101478 @default.
• W3086708017 cites W2106926141 @default.
• W3086708017 cites W2107986694 @default.
• W3086708017 cites W2108094585 @default.
• W3086708017 cites W2110634891 @default.
• W3086708017 cites W2124728103 @default.
• W3086708017 cites W2125123295 @default.
• W3086708017 cites W2137140584 @default.
• W3086708017 cites W2143463421 @default.
• W3086708017 cites W2153771870 @default.
• W3086708017 cites W2158558808 @default.
• W3086708017 cites W2161946327 @default.
• W3086708017 cites W2169515956 @default.
• W3086708017 cites W2237967761 @default.
• W3086708017 cites W2262008519 @default.
• W3086708017 cites W2284550715 @default.
• W3086708017 cites W2318562966 @default.
• W3086708017 cites W2321389840 @default.
• W3086708017 cites W2586453352 @default.
• W3086708017 cites W2594684238 @default.
• W3086708017 cites W2762970810 @default.
• W3086708017 cites W2769069333 @default.
• W3086708017 cites W2781502887 @default.
• W3086708017 cites W2791409908 @default.
• W3086708017 cites W2791687680 @default.
• W3086708017 cites W2792475592 @default.
• W3086708017 cites W2800886158 @default.
• W3086708017 cites W2807410315 @default.
• W3086708017 cites W2900559336 @default.
• W3086708017 cites W2920826237 @default.
• W3086708017 cites W2961282364 @default.
• W3086708017 cites W2982296773 @default.
• W3086708017 cites W2982426301 @default.
• W3086708017 cites W2993536313 @default.
• W3086708017 cites W3004452006 @default.
• W3086708017 cites W3018669258 @default.
• W3086708017 cites W3035616823 @default.
• W3086708017 doi "https://doi.org/10.3390/ijms21186721" @default.
• W3086708017 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7555837" @default.
• W3086708017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32937817" @default.
• W3086708017 hasPublicationYear "2020" @default.
• W3086708017 type Work @default.
• W3086708017 sameAs 3086708017 @default.
• W3086708017 citedByCount "8" @default.
• W3086708017 countsByYear W30867080172022 @default.
• W3086708017 countsByYear W30867080172023 @default.
• W3086708017 crossrefType "journal-article" @default.
• W3086708017 hasAuthorship W3086708017A5045095239 @default.
• W3086708017 hasAuthorship W3086708017A5069198969 @default.
• W3086708017 hasAuthorship W3086708017A5088377898 @default.
• W3086708017 hasAuthorship W3086708017A5090107841 @default.
• W3086708017 hasBestOaLocation W30867080171 @default.
• W3086708017 hasConcept C109316439 @default.
• W3086708017 hasConcept C121608353 @default.
• W3086708017 hasConcept C12554922 @default.
• W3086708017 hasConcept C13245373 @default.
• W3086708017 hasConcept C139770010 @default.
• W3086708017 hasConcept C1491633281 @default.
• W3086708017 hasConcept C178790620 @default.
• W3086708017 hasConcept C18150654 @default.
• W3086708017 hasConcept C185592680 @default.

• next